N03.2
Chronic nephritic syndrome with diffuse membranous glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Chronic nephritic syndrome with diffuse membranous glomerulonephritis is a kidney condition marked by long-lasting inflammation and damage to the tiny filtering units of the kidneys called glomeruli. This condition is categorized under ICD-10 code N03.2. It involves a specific form of glomerulonephritis known as membranous, which affects the structure of the glomerular basement membrane, leading to complications like proteinuria and potential decline in kidney function over time. Understanding this condition can help patients recognize its importance and the need for medical management to preserve kidney health.
Causes & Symptoms
Clinical Causes: Autoimmune diseases, such as systemic lupus erythematosus. Infections, including hepatitis B and hepatitis C. Certain medications and toxins that may trigger immune responses. Inherited genetic disorders that affect kidney structure. Idiopathic cases where no specific cause can be identified.
Key Symptoms: Swelling in the legs, ankles, or around the eyes due to fluid retention. Foamy appearance of urine caused by elevated protein levels. Dark or blood-tinged urine indicating possible bleeding within the kidney filters. High blood pressure which may develop as kidney function declines. Fatigue and general weakness. Decreased urine output in advanced stages.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. These testing methods include urinalysis to detect protein and blood in the urine, blood tests to evaluate kidney function and immune activity, and kidney biopsy to confirm the presence of membranous glomerulonephritis. Imaging studies may also be used to assess the kidneys' size and structure.
Treatment Protocols: Treatment aims to manage symptoms, control immune-related activity, and slow disease progression. Approaches include medications such as corticosteroids and immunosuppressants to reduce inflammation, blood pressure medications like ACE inhibitors or ARBs to protect kidney function, and lifestyle adjustments to manage fluid retention and blood pressure. In some cases, plasmapheresis or other advanced therapies may be considered if the disease is severe or rapidly progressing. Regular monitoring and follow-up care are crucial for adapting treatment plans as needed.
Clinical Advice & FAQs
Billing Guidance
Is N03.2 a billable ICD-10 code?
Yes, N03.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N03.2?
Clinical documentation must specify the nature of Chronic nephritic syndrome with diffuse membranous glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference